Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Rohit Pal

12PUBLICATIONS
14CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsIndustrial microbiology (incl. biofeedstocks)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Jun 19, 2026
Pyrimidine derivatives as anticancer agents targeting kinases: design strategies, biological evaluation, and structure-activity relationship insights.

|Dec 03, 2025
Steroidal Scaffolds as Anticancer Agents: Evolution, FDA Approvals, Synthetic Derivatives, SAR Profiles, and Translational Perspectives.

Prabhugouda Gugal, Hemalatha Kamurthy, Rohit Pal

|Apr 21, 2025
<i>In-silico</i> based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies.

Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar

|Apr 19, 2025
Design, Synthesis, and Molecular Profiling of Pyrimidine-Furan Derivatives Targeting EGFR<sup>WT</sup>, EGFR<sup>T790M</sup>, and EGFR<sup>L858R/T790M/C797S</sup> in NSCLC: In Vitro and In Silico Evaluation.

Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli

|Jan 09, 2025
Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic Breakthroughs.

S Mounika, K Hemalatha, Rohit Pal

|Oct 22, 2024
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationship.

E Haripriya, K Hemalatha, Gurubasavaraja Swamy Purawarga Matada

Pageof 2

Frequent Collaborators

9 joint publications

Gurubasavaraja Swamy Purawarga Matada

4 joint publications

Lalmohan Maji

4 joint publications

Sindhuja Sengupta

3 joint publications

Ghanshyam Teli

3 joint publications

K Hemalatha

2 joint publications

Prasad Sanjay Dhiwar

2 joint publications

Ekta Singh

2 joint publications

Abhishek Ghara

2 joint publications

Nulgumnalli Manjunathaiah Raghavendra

1 joint publications

Ganesh Andhale

Frequent Collaborators

9 joint publications

Gurubasavaraja Swamy Purawarga Matada

4 joint publications

Lalmohan Maji

4 joint publications

Sindhuja Sengupta

3 joint publications

Ghanshyam Teli